US Archives - Page 40 of 80 - European Medical Journal

VISIBLE Study Drives Diversity in Psoriasis Research

In an effort to improve psoriasis research, the VISIBLE clinical trial has made significant strides in diversity, enrolling participants with skin of color (SoC) at an accelerated rate.

Dynamic Model Improves Migrant Tuberculosis Detection

Tuberculosis (TB) remains a persistent health concern among migrants to low-TB-incidence countries, including Canada.

Estrogen-Progesterone Therapy Linked to Autoimmune Risks

A recent study exploring the impact of estrogen and progesterone analog supplementation on autoimmune conditions reveals a concerning association with several diseases.

AI Model Predicts Outcomes for Patients with Breast Cancer on CDK4/6 Inhibitors: SABCS 2024

A new AI-powered model predicts outcomes for breast cancer patients on CDK4/6 inhibitors, offering precise insights into treatment response and enabling personalized care.

Predictors of Psoriatic Arthritis in Juvenile Arthritis

Insights into predicting psoriatic arthritis (PsA) in juvenile idiopathic arthritis (JIA) patients, 18 years after their initial diagnosis, were shared in a recent study.

Burn Patients Face Pneumonia Risk Surge

A newly published study highlights a critical connection between inhalation injury severity and the risk of developing nosocomial pneumonia (NP) in burn patients.

Can Exercise and Brain Stimulation Help Patients With ALS?

A recent meta-analysis sheds light on nonpharmacologic treatments for amyotrophic lateral sclerosis (ALS), specifically active exercise and noninvasive brain stimulation (NIBS).

Genomic Testing Guides Chemotherapy Choices in Breast Cancer: SABCS 2024

In this study, patients with a recurrence scores greater than 31 exhibited significant improvements in survival outcomes when treated with taxane and anthracycline-based chemotherapy.

AI Technology Offers Hope for Faster Diagnosis of Infantile Spasms: AES 2024

AI-powered video analysis could transform the diagnosis of infantile spasms, a severe form of epilepsy in babies, by enabling early detection and treatment, according to new research.

Tamoxifen Reduces Recurrence for Patients with 'Good-Risk' Ductal Carcinoma In Situ: SABCS 2024

Findings, presented at SABCS 2024, support tamoxifen as an effective adjuvant therapy for reducing recurrence in women with “good-risk” DCIS who opt to skip RT.